Twist Bioscience
TWST
219 hedge funds and large institutions have $2.46B invested in Twist Bioscience in 2023 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 54 increasing their positions, 75 reducing their positions, and 20 closing their positions.
135% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 20
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
83% more capital invested
Capital invested by funds: $1.34B → $2.46B (+$1.12B)
13% more funds holding
Funds holding: 194 → 219 (+25)
0.92% more ownership
Funds ownership: 114.81% → 115.74% (+0.92%)
21% less call options, than puts
Call options by funds: $11.8M | Put options by funds: $15M
28% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 75
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$45.4M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$20M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$9.88M |
| 4 |
Man Group
London,
United Kingdom
|
+$6.71M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$46.1M |
| 2 |
State Street
Boston,
Massachusetts
|
-$14.7M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$12.3M |
| 4 |
JP Morgan Chase
New York
|
-$10.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$8.21M |
TWST Hedge Fund Activity: Q4 2023 in Review
219 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2023, worth a combined $2.46B — up 83% from $1.34B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new TWST positions and 20 closed out — a net gain of 27 holders — while 54 added to existing stakes and 75 trimmed.
The largest buyer was Artisan Partners, adding an estimated $45.4M. The largest seller was Millennium Management, cutting an estimated $46.1M.
- 219 institutional investors held Twist Bioscience (TWST) as of Q4 2023, up from 194 in Q3 2023.
- Funds reported $2.46B of Twist Bioscience stock for Q4 2023, up 83% quarter-over-quarter.
- 47 funds opened new Twist Bioscience positions in Q4 2023 and 20 closed out, a net change of +27 holders.
- The largest Twist Bioscience buyer in Q4 2023 was Artisan Partners, an estimated $45.4M added.
- The largest Twist Bioscience seller in Q4 2023 was Millennium Management, an estimated $46.1M sold.
Based on aggregated 13F filings for Q4 2023.